CN102138922B - 盐酸头孢卡品酯组合物及其制备方法 - Google Patents
盐酸头孢卡品酯组合物及其制备方法 Download PDFInfo
- Publication number
- CN102138922B CN102138922B CN 201110035278 CN201110035278A CN102138922B CN 102138922 B CN102138922 B CN 102138922B CN 201110035278 CN201110035278 CN 201110035278 CN 201110035278 A CN201110035278 A CN 201110035278A CN 102138922 B CN102138922 B CN 102138922B
- Authority
- CN
- China
- Prior art keywords
- cefcapene pivoxil
- pivoxil hydrochloride
- label
- compositions
- starch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110035278 CN102138922B (zh) | 2011-02-01 | 2011-02-01 | 盐酸头孢卡品酯组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110035278 CN102138922B (zh) | 2011-02-01 | 2011-02-01 | 盐酸头孢卡品酯组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102138922A CN102138922A (zh) | 2011-08-03 |
CN102138922B true CN102138922B (zh) | 2013-03-27 |
Family
ID=44406866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110035278 Active CN102138922B (zh) | 2011-02-01 | 2011-02-01 | 盐酸头孢卡品酯组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102138922B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104367481A (zh) * | 2014-09-21 | 2015-02-25 | 四川制药制剂有限公司 | 盐酸头孢卡品酯的加工工艺 |
CN104188932A (zh) * | 2014-09-21 | 2014-12-10 | 四川制药制剂有限公司 | 一种盐酸头孢卡品酯组合物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101120927A (zh) * | 2007-09-03 | 2008-02-13 | 江苏正大清江制药有限公司 | 头孢呋辛酯片的湿法制粒工艺 |
JP4336380B1 (ja) * | 2008-11-06 | 2009-09-30 | 塩野義製薬株式会社 | 水懸濁性を向上させた細粒剤 |
CN101756906B (zh) * | 2009-11-02 | 2011-11-16 | 严洁 | 盐酸头孢卡品酯颗粒的药物组合物及其制备方法 |
-
2011
- 2011-02-01 CN CN 201110035278 patent/CN102138922B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102138922A (zh) | 2011-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101184489B (zh) | 药物组合物 | |
CN101829111B (zh) | 含有缬沙坦的固体制剂及其制备方法 | |
JP4707073B2 (ja) | アトルバスタチン経口投与用粒子状医薬組成物 | |
EP2216048A1 (en) | Spherical particle and method for producing the same | |
EP1891952B1 (en) | Pharmaceutical composition of olmesartan medoxomil | |
US20150133489A1 (en) | Compacted moxifloxacin | |
CN100490807C (zh) | 一种头孢呋辛酯脂质体、其制备方法及含有它的药物组合物 | |
CN102860994A (zh) | 一种瑞舒伐他汀钙片及其制备方法 | |
EP3087989B1 (en) | Solid preparations comprising tofogliflozin and method for producing the same | |
CN102138922B (zh) | 盐酸头孢卡品酯组合物及其制备方法 | |
JP2011503010A (ja) | 水分封鎖剤を使用する湿式顆粒化 | |
EP2620140A1 (en) | Crizotinib containing compositions | |
CN103768063A (zh) | 一种盐酸莫西沙星药物组合物及其制备方法 | |
CN102138923B (zh) | 盐酸头孢卡品酯组合物及其制备方法 | |
CN102138924B (zh) | 盐酸头孢卡品酯组合物及其制备方法 | |
CN105343028A (zh) | 一种诺氟沙星的药物组合物及其制备方法 | |
Ogaji et al. | Some characteristics of theophylline tablets coated with samples of grewia gum obtained from a novel extraction | |
CN102670536A (zh) | 头孢克肟分散片的制备方法 | |
CN104473892A (zh) | 一种用于直接压片的法罗培南钠组合物及其制备方法 | |
CN103800334B (zh) | 甲磺酸伊马替尼的药物组合物及其制备方法 | |
CN105796523A (zh) | 一种甲磺酸左氧氟沙星片及其制备工艺 | |
JP2006176496A (ja) | 固形剤およびその製造方法 | |
CN102772403A (zh) | 普拉克索制剂及其制备方法 | |
CN102688209A (zh) | 鲁拉西酮片和制备方法 | |
CN102784115B (zh) | 含有伊潘立酮的口服片剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Du Xuzhao Inventor after: Bai Min Inventor after: He Yuxia Inventor after: Hao Weihua Inventor after: Jin Xiaoli Inventor after: Wang Meng Inventor after: Wu Huanhuan Inventor after: Chen Surui Inventor before: Du Xuzhao Inventor before: Bai Min Inventor before: He Yuxia Inventor before: Wang Meng Inventor before: Wu Huanhuan Inventor before: Chen Surui |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: DU XUZHAO BAI MIN HAO YUXIA WANG MENG WU HUANHUAN CHEN SURUI TO: DU XUZHAOBAI MIN HAO YUXIA HAO WEIHUA JIN XIAOLI WANG MENG WU HUANHUAN CHEN SURUI |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD., Effective date: 20140623 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140623 Address after: 050035 the Yellow River Road, Shijiazhuang high tech Zone, Hebei, No. 226 Patentee after: Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. of CSPC Group Patentee after: Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd., Shiyao Group Address before: 050035 the Yellow River Road, Hebei, Shijiazhuang, No. 226 Patentee before: Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. of CSPC Group |